Dolby insider plans sale of 1,348 common shares

Dolby Laboratories, Inc. insider Ryan H. Nicholson filed to sell common stock through Morgan Stanley Smith Barney LLC.

Rhea-AI Filing Summary

Dolby Laboratories, Inc. insider Ryan H. Nicholson filed to sell common stock through Morgan Stanley Smith Barney LLC. The notice covers 1,348 common shares, with an indicated aggregate value of $83,630.05, to be sold on or after 08/10/2026 on the NYSE. The shares relate to prior restricted stock awards granted in 2020 and 2021. Over the past three months, Nicholson has already sold 357 shares for proceeds of $21,644.91.

Key Figures

Shares to be sold: 1,348 shares Aggregate value of planned sale: $83,630.05 Shares sold in past 3 months: 357 shares +4 more

7 metrics

Shares to be sold 1,348 shares Common stock covered by the notice to be sold on or after 08/10/2026

Aggregate value of planned sale $83,630.05 Value associated with 1,348 Dolby common shares in the planned transaction

Shares sold in past 3 months 357 shares Common shares sold on 08/04/2026 by Ryan H. Nicholson

Proceeds from recent sale $21,644.91 Value of 357 Dolby common shares sold on 08/04/2026

Restricted stock grant 2020 (portion) 510 shares Restricted stock listed with a 12/15/2020 grant date

Restricted stock grant 2020 (additional) 327 shares Additional restricted stock listed with a 12/15/2020 grant date

Restricted stock grant 2021 511 shares Restricted stock listed with a 12/15/2021 grant date

Key Terms

Restricted Stock, Securities To Be Sold, Securities Sold During The Past 3 Months

3 terms

Restricted Stock financial

"Common | 12/15/2020 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Dolby Laboratories (DLB) insider Ryan Nicholson plan to sell under this notice?

Ryan H. Nicholson plans to sell 1,348 shares of Dolby Laboratories common stock. The filing lists these shares with an aggregate value of $83,630.05, to be sold on or after 08/10/2026 through Morgan Stanley Smith Barney LLC on the NYSE.

What type of Dolby (DLB) awards are involved in Ryan Nicholson’s planned stock sale?

The planned sale involves shares from restricted stock awards. These awards were granted on 12/15/2020 and 12/15/2021, with individual components of 510, 327, and 511 shares listed as their sources.

Has Dolby (DLB) insider Ryan Nicholson sold any shares in the last three months?

Yes. In the last three months, Ryan H. Nicholson sold 357 shares of Dolby common stock. The sale occurred on 08/04/2026 and generated proceeds of $21,644.91, according to the recent Form 144 information.

Which broker is handling the planned Dolby (DLB) stock sale for Ryan Nicholson?

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s address is listed as 1 New York Plaza, 8th Floor, New York, NY 10004, acting for Nicholson’s Dolby common stock transaction.

On which exchange are Ryan Nicholson’s Dolby (DLB) shares expected to be sold?

The shares are indicated to be sold on the NYSE. The Form 144 details common stock of Dolby Laboratories with a proposed sale date of 08/10/2026, to be transacted on the New York Stock Exchange through the named broker.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 04:16 PM Accepted by SEC EDGAR 08/10/2026 - 04:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001767009
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	DOLBY LABORATORIES, INC.
SEC File Number	001-32431
Address of Issuer	1275 Market Street San Francisco CALIFORNIA 94103-1410
Phone	(415) 558-0200
Name of Person for Whose Account the Securities are To Be Sold	RYAN H NICHOLSON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1348	83630.05	59416894	08/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/15/2020	Restricted Stock	Issuer			510	12/15/2020	Not Applicable
Common	12/15/2020	Restricted Stock	Issuer			327	12/15/2020	Not Applicable
Common	12/15/2021	Restricted Stock	Issuer			511	12/15/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
RYAN H NICHOLSON 1275 Market Street San Francisco CA 94103-1410	Common	08/04/2026	357	21644.91

144: Remarks and Signature

Remarks
Date of Notice	08/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Ryan Howard Nicholson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)